REFERENCES
- Watson P G, Hayreh S S. Scleritis and episcleritis. Br J Ophthalmol. 1976; 60: 163–222, [PUBMED], [INFOTRIEVE]
- Watson P G. Doyne memorial lecture: the nature and the treatment of scleral inflammation. Trans Ophthalmol Soc UK. 1982; 102: 257–281, [PUBMED], [INFOTRIEVE]
- Sainz de la Maza M, Jabbur N S, Foster C S. An analysis of therapeutic decision for scleritis. Ophthalmology 1993; 100: 1372–1376, [PUBMED], [INFOTRIEVE]
- Watson P G. The diagnosis and management of scleritis. Ophthalmology 1990; 87: 716–720
- Jabs D A, Mudun A, Dunn J P, Marsh M J. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000; 130: 469–476, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Watson P G, Lobascher D J, Sabiston D W, Lewis-Faning E, et al. Double blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol. 1966; 50: 463–490, [PUBMED], [INFOTRIEVE]
- Hayreh S S, Watson P G. Prednisolone-21-stearoglycate in scleritis. Br J Ophthalmol. 1970; 54: 394–398, [PUBMED], [INFOTRIEVE]
- Hakin K N, Ham J, Lightman S L. Use of cyclosporin in the management of steroid dependent non-necrotizing scleritis. Br J Ophthalmol. 1991; 75: 340–341, [PUBMED], [INFOTRIEVE], [CSA]
- Wakefield D, McCluskey P. Cyclosporin therapy for severe scleritis. Br J Ophthalmol. 1989; 73: 743–746, [PUBMED], [INFOTRIEVE]
- Foster C S. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology 1980; 87: 140–150, [PUBMED], [INFOTRIEVE]
- McCarthy M J, Dubord P J, Chalmers A, Kassen B O, et al. Cyclosporine a for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis. J Rheumatol. 1992; 19: 1358–1361, [PUBMED], [INFOTRIEVE]
- Corkill M M, Kirkham B W, Chikanza I C, Gibson T, et al. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomised controlled trial. Br J Rheumatol. 1990; 29: 274–279, [PUBMED], [INFOTRIEVE]
- Kovarsky J, Pegram S B. Bolus intramuscular methylprednisolone acetate as a therapeutic adjunct in rheumatoid arthritis. South Med J. 1986; 79: 1521–1523, [PUBMED], [INFOTRIEVE]
- Li C, Dasgupta B. Corticosteroids in polymyalgia rheumatica—a review of different treatment schedules. Clin Exp Rheumatol. 2000; 18: S56–S57, (Suppl. 20)[PUBMED], [INFOTRIEVE], [CSA]
- Dasgupta B, Gray J, Fernandes L, Olliff C. Treatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone. Ann Rheum Dis. 1991; 50: 942–945, [PUBMED], [INFOTRIEVE]
- Dasgupta B, Dolan M, Panayi S, Fernandes L. An initially double blinded controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of PMR. Br J Rheumatol. 1998; 37: 189–195, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ashoor A A, Ahmed M. Effects of intramuscular depot-corticosteroid on the nasal mucosa in allergic rhinitis. Ann Allergy. 1982; 48: 184–186, [PUBMED], [INFOTRIEVE]
- McNamara R M, Rubin J M. Intramuscular methylprednisolone acetate for the prevention of relapse in acute asthma. Ann Emerg Med. 1993; 22: 1829–1835, [PUBMED], [INFOTRIEVE], [CSA]
- Sood A, Midha V, Sood N, Kaushal V, Awasthi G. Methylprednisolone acetate versus oral prednisolone in moderately active ulcerative colitis. Indian J Gastroenterol. 2002; 21: 11–13, [PUBMED], [INFOTRIEVE], [CSA]
- Tehrani N N, Saeed T, Murray P I. Deep intramuscular methylprednisolone for treatment of cystoid macular oedema in uveitis. Eye. 2000; 14: 691–694, [PUBMED], [INFOTRIEVE]
- McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987; 105: 793–797, [PUBMED], [INFOTRIEVE]
- Meyer P A, Watson P G, Franks W, Dubord P. ‘Pulsed’ immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease. Eye 1987; 1: 487–495, [PUBMED], [INFOTRIEVE]
- Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986; 104: 847–851, [PUBMED], [INFOTRIEVE]
- Croasdale C R, Brightbill F S, Wis M. Subconjuctival corticosteroid injections for non-necrotizing anterior scleritis. Arch Ophthalmol. 1999; 117: 966–968, [PUBMED], [INFOTRIEVE], [CSA]
- Tu E Y, Culberston W W, Pflugfelder S C, Huang A, et al. Therapy of non-necrotising anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology 1995; 102: 718–724, [PUBMED], [INFOTRIEVE], [CSA]
- Zamir E, Read R W, Smith R E, Wang R C, et al. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology 2002; 109: 798–207, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hakin K N, Ham J, Lightman S L. Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Br J Ophthalmol. 1991; 75: 337–339, [PUBMED], [INFOTRIEVE], [CSA]